T-cell reconstitution by thymus transplantation and transfer factor in severe combined immunodeficiency.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 122863)

Published in Pediatrics on January 01, 1975

Authors

G S Rachelefsky, E R Stiehm, A J Ammann, S D Cederbaum, G Opelz, P I Terasaki

Articles by these authors

High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med (1973) 9.90

Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation (1968) 8.51

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol (1978) 6.88

Serum levels of immune globulins in health and disease: a survey. Pediatrics (1966) 6.10

Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50

Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet (1975) 5.15

Autologous stimulation of human lymphocyte subpopulation. J Exp Med (1975) 4.80

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol (2000) 4.70

Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med (1970) 4.40

Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA (1996) 4.33

Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy. N Engl J Med (1977) 4.22

Serotyping for homotransplantation. X. Survival of 196 grafted kidneys subsequent to typing. Transplantation (1967) 4.16

Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med (1978) 4.15

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med (1999) 4.12

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. Lancet (1969) 3.67

Selective IgA deficiency: presentation of 30 cases and a review of the literature. Medicine (Baltimore) (1971) 3.57

Factors in the prognosis of meningococcal infection. Review of 63 cases with emphasis on recognition and management of the severely ill patient. J Pediatr (1966) 3.52

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

Effect of blood transfusions on subsequent kidney transplants. Transplant Proc (1973) 3.42

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22

Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med (1995) 3.11

Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00

Pneumococcal polysaccharide immunization in infants and children. Pediatrics (1978) 2.67

B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA (1984) 2.63

Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. Southern California Pediatric AIDS Consortium. N Engl J Med (1993) 2.58

Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med (1978) 2.52

Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet (1995) 2.50

Elevated cord macroglobulins in the diagnosis of intrauterine infections. N Engl J Med (1966) 2.50

Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med (1998) 2.48

Comparative properties of arginases. Comp Biochem Physiol B Biochem Mol Biol (1996) 2.42

Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med (1990) 2.40

Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev (2000) 2.38

Thoracic duct drainage before and after cadaveric kidney transplantation. Surg Gynecol Obstet (1979) 2.33

Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men. Lancet (1983) 2.30

Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23

The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. Transplantation (1995) 2.13

Influence of test technique on sensitization status of patients on the kidney transplant waiting list. Am J Transplant (2013) 2.12

Equitable allocation of HLA-compatible kidneys for local pools and minorities. N Engl J Med (1994) 2.12

Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res (1973) 2.11

Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. N Engl J Med (1992) 2.09

Failure of rubella herd immunity during an epidemic. N Engl J Med (1973) 2.07

Human renal transplants. I. Glomerular changes. Lab Invest (1967) 2.06

Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res (1984) 2.02

Examine your Morrow Brown needles. J Allergy Clin Immunol (1991) 1.94

Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group. J Infect Dis (1997) 1.93

Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase. N Engl J Med (1976) 1.91

[Immunological aspects of kidney transplantation in Switzerland 1981-1992. Swiss Transplant Work Group Kidney Transplantation]. Schweiz Med Wochenschr (1995) 1.91

Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89

Analysis of HL-A incompatibility in human renal transplants. Tissue Antigens (1971) 1.89

Acquired immune dysfunction in homosexual men: immunologic profiles. Clin Immunol Immunopathol (1983) 1.86

A semimicro mixed leukocyte culture test. Transplantation (1971) 1.85

Deficiency of immune interferon production by leukocytes of normal newborns. Cell Immunol (1980) 1.85

Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. Am J Med Genet (1988) 1.82

Serotyping for homotransplantation. V. Evaluation of a matching scheme. Transplantation (1966) 1.78

Immunologic responses in malnourished children. Am J Clin Nutr (1975) 1.78

Determination of antibody to pneumococcal polysaccharides with chromic chloride-treated human red blood cells and indirect hemagglutination. Appl Microbiol (1972) 1.75

Decreased mononuclear and polymorphonuclear chemotaxis in human newborns, infants, and young children. Pediatrics (1977) 1.70

Enhancement of human kidney allografts by cold B-lymphocyte cytotoxins. Lancet (1978) 1.70

Spinocerebellar ataxia and HLA linkage: risk prediction by HLA typing. N Engl J Med (1977) 1.67

Thymosin activity in patients with cellular immunodeficiency. N Engl J Med (1975) 1.67

Multiple sclerosis: association with HL-A3. Tissue Antigens (1972) 1.65

Successful renal allografts across a positive cross-match for donor B-lymphocyte alloantigens. Lancet (1976) 1.63

Disturbance of HL-A antigen frequency in Psoriasis. N Engl J Med (1972) 1.63

Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency. J Clin Invest (1978) 1.61

Cross reactions between human transplantation antigens and bacterial lipopolysaccharides. Transplantation (1973) 1.60

Thoracic duct fistula and renal transplantation. Ann Surg (1979) 1.60

Maternal transmission of acquired immune deficiency syndrome. Pediatrics (1984) 1.60

Influence of race on kidney transplant survival. Transplant Proc (1977) 1.58

Increased prevalence of W27 in juvenile rheumatoid arthritis. N Engl J Med (1974) 1.58

Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow. Crucial role of histocompatiility matching. N Engl J Med (1969) 1.58

Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion (2000) 1.58

Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57

Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem Biophys Res Commun (1995) 1.57

HLA matching and cadaver kidney transplant survival in North America: influence of center variation and presensitization. Transplantation (1977) 1.56

Empirical validation of the Essen-Möller probability of paternity. Am J Hum Genet (1986) 1.56

Acquired immunodeficiency in an infant: possible transmission by means of blood products. Lancet (1983) 1.55

Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W. 27. Ann Rheum Dis (1974) 1.55

Anti-HLA antibodies after solid organ transplantation. Transplantation (2000) 1.54

Impaired in-vitro lymphocyte responses in patients with elevated pentachlorophenol (PCP) blood levels. Arch Environ Health (1995) 1.52

Arginase activity in endothelial cells: inhibition by NG-hydroxy-L-arginine during high-output NO production. Am J Physiol (1996) 1.50

The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J Clin Invest (1972) 1.50

Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation. Am J Transplant (2015) 1.50

Cloning and characterization of the human type II arginase gene. Genomics (1996) 1.49

HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16. N Engl J Med (1976) 1.49

Decreased rosette-forming lymphocytes in malnutrition and intrauterine growth retardation. J Pediatr (1974) 1.48

HLA and the inheritance of multiple sclerosis: linkage analysis of 72 pedigrees. Am J Hum Genet (1980) 1.46

Cytotoxins in disease. 3. Antibodies against lymphocytes produced by vaccination. Transplantation (1970) 1.46